Mucosal-associated invariant T (MAIT) cells are evolutionarily conserved T cells that are restricted by the non-classical major histocompatibility complex class-1b molecule MR1. MAIT cells recognize riboflavin (vitamin B2) derivatives in a MR1-dependent manner. Following antigen recongnition, MAIT cells rapidly produce Th1/Th17 cytokines, such as interferon-γ and interleukin-17, in an innate-like manner. MAIT cells maintain an activated phenotype throughout the course of an infection, secrete inflammatory cytokines, and have the potential to directly kill infected cells, thus, playing an important role in controlling the host response. In this review, we discuss current knowledge regarding the role of MAIT cells in infectious diseases, cancers, and autoimmune diseases. (J Rheum Dis 2015;22:337-345)
INTRODUCTION
Innate-like lymphocytes, such as invariant natural killer T (iNKT) cells, have gained great interest since their discovery, as these cells lie at the interface between innate and adaptive immune responses. iNKT cells are memory cells bearing a semi-invariant T cell receptor (TCR) through which they recognize self-and bacterial-derived lipid antigens presented by CD1d molecules. iNKT cells facilitate adaptive immune responses by inducing maturation of dendritic cells during a pathogenic infection [1] . In addition to iNKT cells, mucosal-associated invariant T (MAIT) cells, which are another innate-like lymphocyte cell subset, have been the focus of much research. These cells recognize a unique family of bacterial-derived metabolites in the context of the major histocompatibility complex (MHC) class I-like molecule MR1 [2] .
MAIN SUBJECTS MAIT cell definition and phenotype
MAIT cells are identified based on their surface phenotype and mucosal tissue localization. The MAIT cell invariant TCR Vα7.2-Jα33/12/20 in humans was first described in 1993 as one of the few preferentially used TCRs in the double-negative T cell compartment [3] . This finding was the first evidence of a new subset of T cells possibly recognizing a limited set of antigens in the context of non-polymorphic antigen-presenting molecules. It was not until 1999 that the MAIT cell subset was defined as a conserved subpopulation distinct from MHC class I-and CD1-restricted cells with an activated/memory phenotype [4] . That study also reported that human MAIT cell TCR-β chain usage was primarily TRBV6 or TRBV20. Initial research into MAIT cells has been hampered by the lack of specific reagents; however, generation of a monoclonal antibody specific for the Vα7.2 TCR chain [5] and MR1 tetramers [6] have recently enabled functional and phenotypic analyses of MAIT cells and brought them to [11] .
the forefront of innate-like lymphocyte research. MAIT cells are defined as CD3＋Vα7.2＋CD161＋＋ and either CD8＋ or double-negative T cells [5, 7] . MR1-loaded tetramer experiments have also identified a small subset of CD4＋ MAIT cells [6] . All human MAIT cell subsets express the PLZF transcription factor, which directs the effector program of the iNKT cell lineage [8] . However, murine MAIT cells do not express PLZF [5] ; thus, the functional relevance of this observation is currently unclear. MAIT cells can also be defined based on co-expression of interleukin (IL)-18Rα [7] and CD26 [9] . Furthermore, peripheral blood MAIT cells in adults have an effector memory phenotype defined as CD45RO＋, CD62Llo, CD95hi CD122int, and CD127int, and they express the tissue-homing chemokine receptors CCR5, CCR6, CXCR6, and CCR9 [10] . In contrast, MAIT cells do not express CCR7, which is a marker for homing to lymph nodes. The distinct memory phenotype and peripheral location of these cells are linked to their unique developmental pathway [2] .
MAIT cells and iNKT cells
Conventional CD4＋ and CD8＋ T cells recognize a wide range of peptide antigens by expressing a TCR heterodimer composed of highly variable α-and β-chains. In contrast, two distinct innate-like αβ TCR T cell populations have been identified with restricted T cell repertoires characterized by expression of an invariant or semi-invariant TCRVα chain [11] (Table 1) . Human MAIT cells express the canonical Vα7.2-Jα33 chain (and the orthologous Vα19-Jα33 in mice), whereas human iNKT cells express the invariant Vα24-Jα18 chain (Vα14-Jα18 in mice) [3, 4, 12] . The resulting semi-invariant TCR in iNKT cells recognizes lipid-based ligands presented by CD1d molecules [12] . Interestingly, MAIT cells recognize a novel microbial molecular pattern class derived from vitamin B-based metabolites, which are presented by MR1 (Figure 1 ) [13, 14] .
MAIT microbial reactivity
An intimate relationship between MAIT cells and microbial flora was suspected early on because MAIT cells are absent from germ-free mice but can be recovered after mono-microbial reconstitution [7, 15] . Moreover, the human thymus and cord blood have few, naive MAIT cells but they rapidly become memory after birth [5] . In fact, both human and mouse MAIT cells directly detect bacterially infected cells as shown by their upregulation of activation markers and cytokine production following co-culture with antigen presenting cells (APC) and bacteria [7, 16] . This reactivity is MR1-dependent and induced by a wide range of microbes, including Gram negative and positive bacteria as well as yeasts. Interestingly, APCs stimulated with innate receptor ligands, such as lipopolysaccharide, peptidoglycans, and microbial nucleic acids, fail to activate MAIT cells, suggesting that antigen recognition by MAIT cells likely does not depend on upregulation of an endogenous molecule when triggered innately, as in NKT cells [17] . In addition, when MR1-overexpressing cells are fixed with glutaraldehyde, they can still activate MAIT cells in the presence of bacteria [7] . Taken together, these results strongly suggest that MR1 is an exogenous highly conserved microbial-derived molecule [18] .
MR1, invariant TCR, and vitamin B metabolites
MR1 is an MHC-I like monomorphic protein that is highly conserved across most mammalian species (90% sequence homology between human and mice), allowing for a high level of functional cross-reactivity [19] . The human MR1 gene was first described in 1995 and is located near the CD1 gene, encoding for another MHC-like protein on chromosome 1 [20, 21] . In 2003, the connection between MR1 and MAIT cells was made by demonstrating the central role of MR1, along with commensal flora and B cells, in MAIT cell development [15] . MR1 is ubiquitously transcribed in all cell types, but endogenous cell surface expression levels are typically very low, suggesting that quantitatively limiting antigens may be required to increase MR1 presentation [19, 22, 23] . Human MAIT cells are most known for dominant expression of a semi-invariant TCR Vα7.2/Jα33 α-chain based on Arden nomenclature (or TRAV1-2/TRAJ33 based on IMGT) [4] . More recently, the MAIT TCR repertoire was shown to include additional Jα (TRAJ12 and TRAJ20) regions with less frequent usage by cell sorting and TCR sequencing with the antigen-loaded MR1 tetramer (or the combination of anti-Vα7.2 and anti-CD161 monoclonal antibodies) [6, 24, 25] . The MAIT TCR α-chain contains a complementarity-determining region 3 loop of constant length with two variable amino acids in the V-J junction located at the base of this loop [3, 25, 26] . Use of the MAIT TCR β-chain has no apparent restriction for use of Jβ; however, there is a bias towards use of Vβ13 and Vβ2 (or TRBV6 and TRBV20 based on IMGT) [3, 4, 27] .
Yeast and many bacteria can activate MAIT cells in an MR1-restricted manner, suggesting that closely related antigens common to these microbes specifically bind MR1 [7] . Surprisingly, denatured MR1 molecules form folded complexes with β2-microglobulin in cell culture media containing several vitamin supplements uniquely synthesized by bacteria and plants, but not mammals. This ultimately led to the discovery of vitamin B metabolites as a new class of antigens [14] . The first MR1-binding ligand to be identified was 6-formylpterin (6-FP), a photodegradation product of vitamin B9 (folic acid) [14] . Although 6-FP specifically upregulates cell surface ex-pression of MR1 on human lymphoid C1R cells, 6-FP does not activate MAIT cells, leading Kjer-Nielsen et al. [14] to a wider search for the natural activating ligand. These natural MAIT cell antigens were identified by the molecular formula C12H18N4O7 from a Salmonella typhimurium supernatant by liquid chromatography-mass spectrometry [14] . A search for potential compounds matching this formula included the riboflavin derivatives (vitamin B2) reduced 6-hydroxymethyl-8-D-ribityllumazine (rRL-6-CH2OH) (C12H18N4O7), 7-hydroxy-6-methyl-8-D-ribityllumazine (C12H16N4O7), and 6,7-dimethyl-8-D-ribityllumazine (C13H16N4O6) [14] . Indeed, these three compounds activate MAIT cells in an MR1-dependent manner in cellular assays [14] . At this point, rRL-6-CH2OH seemed to be the most potent activator of MAIT cells in vitro and ex vivo [14] . One study characterized additional MR1 ligands, called 'neo-antigens' [13] . Neo-antigens generated by non-enzymatic modification of 5-amino-6-D-ribityllumazine using glyoxal or methylglyoxal are simple adducts: 5-(2-oxoethylideneamino)-6-D-ribitylaminouracil (5-OE-RU) and 5-(2-oxopropylideneamino)-6-D-ribitylaminouracil (5-OP-RU), respectively. Although 5-OP-RU and 5-OE-RU are unstable intermediates, they are trapped by MR1 as reversible covalent Schiff base complexes that can activate MAIT cells, suggesting that molecular bi-products created from the interaction between microbial-and potentially host-derived small organic molecules may represent new antigens for MAIT cells [28] .
MAIT cell function
MAIT cells produce various cytokines and kill infected cells via granule exocytosis after MR1-dependent and MR1-independent activation (Figure 2) . A number of studies have shown that adult MAIT cells are terminally differentiated and are less responsive to TCR signaling; thus, resulting in lower production of interferon (IFN)-γ and cell proliferation [5, 10] . In contrast, MAIT cells derived from cord blood or fetal tissues readily proliferate under TCR stimulation [5, 29] . This lack of responsiveness to TCR stimulation by adult MAIT cells can be overcome by adding an innate signal from either the CD28 co-receptor or the cytokines IL-12 and/or IL-18 to induce high levels of IFN-γ and strong proliferation [30, 31] .
1) Cytokine production
MAIT cells produce Th1, Th2, and Th17 cytokines upon activation. Upon stimulation with phorbol 12-myristate 13-acetate (PMA), ionomycin, or bacteria, human MAIT cells produced IFN-γ, tumor necrosis factor (TNF)-α, IL-2, IL-17, and macrophage inflammatory protein-1β, and to a lesser extent IL-4 and IL-10 [10, 25, 27, 32] . One study used multi-parametric flow cytometry to confirm the presence of distinct subsets of circulating MAIT cells releasing different combinations of cytokines [27] . Furthermore, MAIT cells from the small intestine produce IL-22 in response to Escherichia coli, but this was not observed in MAIT cells from liver or lungs [29] . Thus, MAIT cells have different cytokine profiles according to their peripheral location, possibly reflecting local environmental imprinting.
2) Cytotoxicity
MAIT cells detect and kill bacterial-infected cells in a MR1-dependent manner [33, 34] . MAIT cells are activated by a broad range of bacteria by detecting vitamin B metabolites presented by MR1. Cytotoxicity occurs primarily via exocytosis of cytotoxic granules containing perforin and granzyme (Gr), which are key granule proteins required for the Gr transport channel and apoptosis through caspase activation, respectively. Of five Gr isoforms (GrA, GrB, GrH, GrK, and GrM) in humans, GrB is directly linked to cytotoxic activity of CD8＋ T cells [35, 36] . Interestingly, human resting MAIT cells have no GrB and low perforin expression, but high expression levels of GrA and GrK [34] . However, after activation upon antigen recognition, MAIT cells rapidly induce GrB and perforin production, licensing these cells to lyse their cognate target cells [33, 34] . GrB is upregulated in an MR1-and co-stimulation-dependent manner, whereas perforin is upregulated in an MR1-independent manner and requires several factors, such as IL-2, IL-7, or IL-15 [34] . This observation suggests that GrB expression in MAIT cells may be more tightly regulated than that of perforin. The cytotoxicity of activated MAIT cells to infected cells may have an important role controlling intracellular bacterial infections by Shigella and Mycobacterium tuberculosis [34] .
MR1-independent activation
MAIT cells have been implicated in a number of inflammatory conditions independent of bacterial infection. MAIT cells are enriched in the liver of patients with chronic hepatitis C infection, autoimmune hepatitis, and primary biliary cirrhosis, and they are also found in the brain and skin of patients with multiple sclerosis (MS) and patients with psoriasis, respectively [37] [38] [39] . Overall, these findings strongly suggest that some mechanisms driving activation of MAIT cells bypass MR1-dependent activation. Furthermore, MAIT cells also respond to infection in an MR1-independent manner. The high expression of IL-18R on MAIT cells suggests that MAIT cells, like NK cells, are activated after stimulation by IL-18 and IL-12 [32, 37] . Ussher et al. [31] used THP-1 cells as APCs to show that E. coli and Enterococcus faecalis induce sufficient IL-12 and IL-18 to activate MAIT cells. E. coli contains the riboflavin synthetic pathway and activates MAIT cells via MR1, whereas E. faecalis, which lacks the riboflavin synthetic pathway, activates MAIT cells via an MR1-independent pathway solely dependent on IL-12 and IL-18 [7, 14] . In addition, toll-like receptor agonists can indirectly activate MAIT cells via this mechanism [31] . These findings suggest that MAIT cells can respond to viruses and some bacteria that do not contain MR1 ligands or sterile inflammatory conditions beyond bacterial infection with the riboflavin synthetic pathway [31] .
Circulating MAIT cell levels in healthy adults
MAIT cell levels in peripheral blood vary widely (0.19% to 21.7%; mean, ∼2%), and are lower in elderly subjects than in young subjects [40] . No sex difference has been observed in circulating MAIT cell levels. Lee et al. [40] showed that circulating MAIT cell levels decline annually by 3.2% among men and 1.8% among women. Notably, the proportion of CD4＋ MAIT cells increase with age, whereas that of CD8＋ MAIT cells decrease with age. In addition, production of IL-4 by MAIT cells increases in elderly subjects, showing a Th1 to Th2 shift in the cytokine profile [40] .
MAIT cells in infectious diseases
The role of MAIT cells in human disease has not been fully assessed due to difficulties of obtaining tissue samples. However, a number of interesting associations have been reported between the frequency of MAIT cells in peripheral blood and disease [41] . Fewer MAIT cells are present in peripheral blood compared to healthy controls during an active M. tuberculosis infection [7, 16, [42] [43] [44] . Consistent with these findings, we and other groups have observed that all critically ill patients with severe bacterial or viral infections and acute cholecystitis have low MAIT cell counts compared to those of healthy controls [45, 46] . This finding was least pronounced in patients with severe viral infections, and most striking in patients infected with bacteria other than Streptococcus species [46] . This finding suggests that loss of peripheral MAIT cells could be due, in part, to compartmentalization during disease [7, 16] . Interestingly, the authors also observed that individuals with persistently depleted MAIT cells on day 4 post-admission were at increased risk for subsequent nosocomial infections. MAIT cells are depleted from the blood in patients with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) [37, 47, 48] . The loss of peripheral MAIT cells is potentially due to their relocation to the liver during HCV infection. Moreover, the frequency of IFN-γ and IL-17 dual-expressing CD8＋ T cells in the liver, which is a proxy for MAIT cells, is inversely correlated with fibrosis score, suggesting that they either play a protective role during HCV infection, or that they are progressively lost from the liver with increasing fibrosis, which could contribute to the higher rates of bacteremia seen in patients with cirrhosis [49, 50] . The loss of blood CD161＋＋ MAIT cells occurs early during HIV infection and persists despite otherwise successful anti-retroviral therapy [42, 47, 48, 51] , although the nature of this perturbation is unclear. Cosgrove et al. [48] reported that MAIT cells, defined as CD161＋＋ CD8＋ T cells by flow cytometry, were depleted as a proportion of the blood CD8＋ T cell population. They proposed that this depletion was due, at least in part, to activation-induced cell death from overstimulation secondary to microbial translocation. Leeansyah et al. [47] also observed a decrease in the size of the CD161＋＋Vα 7.2＋ population but suggested that this was due to downregulation of CD161 and functional exhaustion of MAIT cells. The decline and possible impaired activation of MAIT cells in patients with HIV likely affect the ability of MAIT cells to control bacteria and yeast infections and, as a result, leave the host extremely vulnerable and contribute to the pathogenesis of acquired immune deficiency syndrome [2] .
MAIT cells in autoimmune diseases
The capacity of MAIT cells to respond to cytokine stimulation, as described above, raises the possibility that these cells may also play a role in autoimmune disorders [2] .
1) Multiple sclerosis and psoriasis
The role of MAIT cells in MS has been studied extensively. The MAIT cell TCR was localized to the central nervous system using single-strand conformation polymorphism analysis in autoptic specimens [52] . A normal frequency of MAIT cells is found in the blood of patients with MS and MAIT cells are also detected in the cerebrospinal fluid of relapsing patients, suggesting a role for MAIT cells in the progression of this disease, which was functionally explored in a study using a mouse model of experimental autoimmune encephalitis (EAE). MAIT cells protected against EAE in transgenic mice overexpressing the MAIT cell TCR by suppressing Th1 cytokine production and increasing of IL-10 production by B cells [53] . It was also observed that EAE is exacerbated in MR1 knockout mice, suggesting a new regulatory role for MAIT cells. Conflicting results have emerged from studies assessing the distribution of circulating MAIT cells in patients with MS. A study of an Italian cohort assessing MAIT cells from monozygotic twins with discordant disease states showed a greater number of circulating CD8＋ CD161＋＋ cells in patients with MS than that in their healthy twin [38] . In contrast, a study of a Japanese cohort showed a decrease in the number of circulating MAIT cells in patients with MS compared to that in healthy controls [54] . This discrepancy emphasizes the difficulties of studies with human subjects and suggests that variations in commensal flora or lifetime infection burden may have affected the MAIT cell frequencies in the two populations.
IL-17A is a vital component in the etiology of psoriasis [54] . As MAIT cells produce this cytokine, it was thought that they might be the CD8＋ cells previously observed in psoriatic lesions. MAIT cells are indeed present in psoriatic lesions along with Th17 cells [39] . This finding pro-vided evidence that MAIT cells may contribute to psoriasis; however, their participation in this setting has not been explored.
2) Inflammatory bowel disease and celiac disease
The location of MAIT cells in the small intestinal mucosa makes them relevant in the pathogenesis of intestinal inflammatory disorders, such as the inflammatory bowel diseases (IBD), Crohn's disease and ulcerative colitis. One study reported that the number of circulating MAIT cells decreases in patients with Crohn's disease and ulcerative colitis compared to that in healthy controls [55] . A similar observation was reported for the number of circulating MAIT cell in patients with celiac disease [56] . More MAIT cells are found in inflamed compared to healthy tissues [55] . A functional assessment of MAIT cells from patients with IBD showed increased IL-17 production upon stimulation along with increased IL-22 in patients with ulcerative colitis but decreased IFN-γ secretion in patients with Crohn's disease. This first demonstration of activated MAIT cells in inflamed gut tissues warrants further investigation as to their potential pathogenic role.
3) Rheumatic diseases
MAIT cells have also been studied in the context of rheumatic diseases. MAIT cells have been implicated to serve as effector cells in a murine model of collagen-induced arthritis [57] . Cho et al. [25] demonstrated that patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) have lower circulating levels of MAIT cells. Furthermore, MAIT cells have been detected in higher proportions in the synovial fluid of patients with RA than in blood. MAIT cells in patients with SLE have impaired activation, as they produce less IFN-γ when challenged with bacteria or stimulated with PMA and ionomycin. This impaired function was more prominent in individuals with a lower number of MAIT cells, suggesting a correlation between MAIT cell number and function. In contrast, IFN-γ secretion is preserved in patients with RA. Expression of the inhibitory molecule programmed death-1 (PD-1) was assessed to determine whether it correlates with MAIT cell dysfunction, and higher PD-1 expression was detected on MAIT cells in patients with SLE than those with RA or healthy controls. However, MAIT cell activation was only partially restored after blocking PD-1, indicating that other negative regulatory mechanisms may be contributing to MAIT cell dysfunction in SLE. These abnormalities possibly contribute to the dysregulated mucosal immunity in SLE.
MAIT cells in cancers
A less explored area is the potential role of MAIT cells in cancers. One study suggested MAIT cells may be present in renal and brain cancers after detecting their TCR in these tissues [58] . This presence in renal and brain cancers correlated with the presence of pro-inflammatory cytokines in the tumor tissues, suggesting that they could have anti-neoplastic functions. Sundström et al. [59] showed that MAIT cells infiltrate colon tumors but their ability to produce IFN-γ is substantially reduced. They suggested that MAIT cells have the capacity to promote local immune responses to tumors, but that factors in the tumor microenvironment act to reduce IFN-γ production by MAIT cells. Furthermore, our unpublished data show that significantly fewer MAIT cell are circulating in patients with mucosal-associated cancers (e.g., gastric, colon, and lung cancers) than those in healthy subjects. MAIT cells migrate to the cancer tissues.
CONCLUSION
MAIT cells may be an ideal target to enhance immune responses with their ability to alter the cytokine microenvironment to pro-inflammatory, directly kill infected cells, potential to enhance adaptive immune responses, and the recent discovery of their activating ligands. Understanding of the potential of these cells could help design more targeted vaccines and effective immunotherapies. The role of MAIT cells during infection is only beginning to be established, with their early infiltration into infected tissues, production of pro-inflammatory cytokines, and roles assisting an effective adaptive immune response. The effector functions of MAIT cells in autoimmune diseases and cancers are also being explored. The integral roles of MAIT cells in the progression of infectious diseases, cancers, and autoimmune diseases makes them an ideal target for enhancing immune responses.
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